<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A multicenter study of <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease in France confirms the male predominance (62 p </plain></SENT>
<SENT sid="1" pm="."><plain>cent), the mean <z:hpo ids='HP_0011007'>age of onset</z:hpo> in the 4th decade, the frequent muco-cutaneous, ocular, articular manifestations (94 p </plain></SENT>
<SENT sid="2" pm="."><plain>cent), the <z:e sem="disease" ids="C0585186" disease_type="Disease or Syndrome" abbrv="">skin hypersensitivity</z:e> (68 p </plain></SENT>
<SENT sid="3" pm="."><plain>cent) </plain></SENT>
<SENT sid="4" pm="."><plain>The forms with <z:hpo ids='HP_0002829'>arthralgia</z:hpo> predominate; the knees are especially affected; <z:hpo ids='HP_0001369'>arthritis</z:hpo> has a favorable course; the para-articular forms are infrequent and in 4 cases, are associated with ankylosing <z:e sem="disease" ids="C0949690" disease_type="Disease or Syndrome" abbrv="">spondylarthritis</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>HLA B5 is found in 47 p. cent of the cases </plain></SENT>
<SENT sid="6" pm="."><plain>HLA-<z:chebi fb="13" ids="33611">B12</z:chebi> in 22 p. cent </plain></SENT>
<SENT sid="7" pm="."><plain>HLA-B5 is associated with eye involvement in 62 p. cent of the cases, HLA-<z:chebi fb="13" ids="33611">B12</z:chebi> is associated with skin involvement in 67 p. cent of the cases </plain></SENT>
<SENT sid="8" pm="."><plain>The effectiveness of <z:chebi fb="0" ids="23359">colchicine</z:chebi> and, at a lesser degree, of steroids, is confirmed </plain></SENT>
</text></document>